CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 160 enrolled
Drug / intervention
SERI® Surgical Scaffolddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01256502
NCT01256502N/ACompleted
CompareCT.gov

The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery

Sofregen Medical, Inc.·interventional·Posted Dec 8, 2010·Updated Nov 6, 2017

In Brief

A clinical study evaluating SERI® Surgical Scaffold for Breast Reconstruction. Completed, enrolled 160 participants across 1 site.

Detailed Summary

The purpose of the study is to obtain clinical experience with the use of SERI® Surgical Scaffold for tissue support and repair in breast reconstruction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Reconstruction
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 8, 2010
Enrollment StartOct 1, 2010
Primary CompletionOct 1, 2012
Study CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.6 years ago

Interventions

SERI® Surgical Scaffolddevice

Breast reconstruction surgery